# OGEN (Oragenics, Inc.) - SEC EDGAR Financial Statements

> Oragenics, Inc. reported $3.28M in total assets and a net loss of $9.62M through December 31, 2025 from SEC EDGAR filings.

- Canonical: https://convexityos.com/fundamentals/OGEN
- Markdown: https://convexityos.com/fundamentals/OGEN.md
- SEC CIK: 0001174940
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 21, 2026, 05:12 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001174940&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2025 | -- | Dec 31, 2025 |
| Operating Income | FY 2025 | -$9.94M | Operating profit |
| Net Income | FY 2025 | -$9.62M | GAAP bottom line |
| Diluted EPS | FY 2025 | -$2.13 | Split-adjusted |
| Free Cash Flow | FY 2025 | -- | Operating CF less CapEx |
| Cash & ST Investments | Sep 30, 2026 | $2.23M | Total debt: -- |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | -- | -- | $38K | $132K | $87K | -- | -- | -- | $0 | $0 |
| Cost of Revenue | -- | -- | -- | -- | -- | -- | -- | -- | $0 | $0 |
| **Gross Profit** | -- | -- | -- | -- | -- | -- | -- | -- | $0 | $0 |
| Research & Development | $2.39M | $4.11M | $15.49M | $10.07M | $10.59M | $22.11M | $12.12M | $5.97M | $3.54M | $4.75M |
| Total Operating Expenses | $9.36M | $10.56M | $20.94M | $14.55M | $15.86M | $26.64M | $15.88M | $9.99M | $6.72M | $8.54M |
| **Operating Income** | -$9.36M | -$10.56M | -$20.90M | -$14.42M | -$15.77M | -$26.64M | -$15.88M | -$9.99M | -$6.72M | -$8.54M |
| **EBITDA** | -- | -- | -$20.88M | -$14.38M | -$15.73M | -$26.59M | -$15.81M | -$9.96M | -$6.65M | -$8.47M |
| Interest Income | $182K | $46K | $210K | $136K | $76K | $89K | $320K | $87K | $10K | $40K |
| Interest Expense | $786K | $30K | $31K | $15K | $16K | $11K | $7.3K | $5.8K | $216K | $4.1K |
| Income Before Tax | -$9.98M | -$10.57M | -$20.66M | -$14.29M | -$15.71M | -$26.43M | -$15.57M | -$9.91M | -$6.73M | -$8.50M |
| Income Tax Expense | -$137K | -- | -- | -- | -- | -- | -- | $0 | $0 | $0 |
| **Net Income** | -$9.84M | -$10.57M | -$20.66M | -$14.29M | -$15.71M | -$26.43M | -$15.57M | -$9.91M | -$6.73M | -$7.01M |
| Basic EPS | -$4.56 | -$47.88 | -$18,753.45 | -$14,524.73 | -$989,624.60 | -$57,493.64 | -$45,260.95 | -$106,424.40 | -$167,587.85 | -$1,920,532.29 |
| **Diluted EPS** | -$4.56 | -$47.88 | -$18,753.45 | -$14,524.73 | -$17,125.77 | -$57,493.64 | -$45,260.95 | -$106,424.40 | -$167,587.85 | -$1,920,532.29 |
| Basic Shares Outstanding | 2.2M | 220.7K | 1.1K | 984 | 16 | 462 | 346 | 107 | 40 | 4 |
| Diluted Shares Outstanding | 2.2M | 220.7K | 1.1K | 984 | 923 | 462 | 346 | 107 | 40 | 4 |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Research & Development | $1.58M | $1.18M | $645K | $671K | $931K | $450K | $342K | $1.67M |
| Total Operating Expenses | $2.60M | $2.59M | $2.26M | $2.50M | $3.12M | $1.71M | $2.03M | $3.36M |
| **Operating Income** | -$2.60M | -$2.59M | -$2.26M | -$2.50M | -$3.12M | -$1.71M | -$2.03M | -$3.36M |
| Interest Income | $14K | $30K | $41K | $87K | $68K | $17K | $10K | $11K |
| Interest Expense | $6.6K | $414 | $3.7K | $7.5K | $7.0K | $572K | $199K | $11K |
| Income Before Tax | -$2.62M | -$2.58M | -$2.22M | -$2.42M | -$3.07M | -$2.27M | -$2.22M | -$3.35M |
| Income Tax Expense | -$21K | -$46K | -$23K | -- | -- | -- | -- | -- |
| **Net Income** | -$2.60M | -$2.53M | -$2.20M | -$2.29M | -$3.07M | -$2.27M | -$2.22M | -$3.35M |
| Basic EPS | -$0.58 | -$0.57 | -$0.51 | -- | -$1.96 | -$3.10 | -$3.65 | -- |
| **Diluted EPS** | -$0.58 | -$0.57 | -$0.51 | -- | -$1.96 | -$3.10 | -$3.65 | -- |
| Basic Shares Outstanding | 4.5M | 4.4M | 4.3M | -- | 1.6M | 731.8K | 607.2K | -- |
| Diluted Shares Outstanding | 4.5M | 4.4M | 4.3M | -- | 1.6M | 731.8K | 607.2K | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $4.40M | $865K | $3.48M | $11.43M | $27.27M | $17.64M | $18.27M | $20.21M | $6.17M | $4.08M |
| Short-Term Investments | $4.00M | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| **Cash & Short-Term Investments** | $8.40M | $865K | $3.48M | $11.43M | $27.27M | $17.64M | $18.27M | $20.21M | $6.17M | $4.08M |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | -- | -- | -- | -- | $0 |
| Inventory | -- | -- | -- | -- | -- | -- | -- | -- | -- | $0 |
| **Total Current Assets** | $10.07M | $1.47M | $3.87M | $14.29M | $27.71M | $17.98M | $18.84M | $21.93M | $7.19M | $4.22M |
| Property, Plant & Equipment, Net | -- | -- | $0 | $121K | $46K | $43K | $92K | $116K | $22K | $87K |
| **Total Non-Current Assets** | $0 | $0 | $1.10M | $469K | $524K | $698K | $915K | $116K | $22K | $87K |
| **Total Assets** | $10.07M | $1.47M | $4.97M | $14.76M | $28.23M | $18.68M | $19.75M | $22.05M | $7.21M | $4.31M |
| Accounts Payable | -- | $1.14M | $1.24M | $247K | $855K | $330K | $1.21M | $829K | $618K | $461K |
| Deferred Revenue (Current) | -- | -- | -- | -- | -- | -- | -- | -- | -- | $0 |
| **Total Current Liabilities** | -- | -- | $1.80M | $1.60M | $1.45M | $1.34M | $1.85M | $1.17M | $899K | $1.34M |
| **Total Non-Current Liabilities** | -- | -- | $0 | $152K | $300K | $494K | $671K | $0 | $0 | $0 |
| **Total Liabilities** | $1.79M | $1.68M | $1.80M | $1.75M | $1.74M | $1.84M | $2.52M | $1.17M | $899K | $1.34M |
| **Total Debt (incl. Leases)** | -- | -- | $9.8K | $357K | $398K | $671K | $836K | -- | -- | -- |
| Common Stock | $4.3K | $419 | $3.1K | $2.0K | $2.0K | $92K | $46K | $29K | $4.9K | $4.9K |
| Retained Earnings | -$226.6M | -$216.8M | -$206.2M | -$185.6M | -$171.3M | -$154.4M | -$127.4M | -$111.4M | -$101.4M | -$94.67M |
| **Total Stockholders' Equity** | $8.28M | -$212K | $3.17M | $13.01M | $26.49M | $16.84M | $17.23M | $20.88M | $6.32M | $2.97M |
| Total Equity | $8.28M | -$212K | $3.17M | $13.01M | $26.49M | $16.84M | $17.23M | $20.88M | $6.32M | $2.97M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $2.23M | $3.86M | $6.11M | $4.40M | $11.40M | $1.97M | $3.42M | $865K |
| Short-Term Investments | -- | -- | -- | $4.00M | -- | -- | -- | -- |
| **Cash & Short-Term Investments** | $2.23M | $3.86M | $6.11M | $8.40M | $11.40M | $1.97M | $3.42M | $865K |
| **Total Current Assets** | $3.28M | $5.49M | $7.49M | $10.07M | $12.71M | $2.14M | $3.87M | $1.47M |
| **Total Non-Current Assets** | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| **Total Assets** | $3.28M | $5.49M | $7.49M | $10.07M | $12.71M | $2.14M | $3.87M | $1.47M |
| Accounts Payable | -- | -- | -- | -- | -- | -- | $772K | $1.14M |
| **Total Liabilities** | $2.19M | $1.82M | $1.31M | $1.79M | $2.87M | $4.27M | $3.73M | $1.68M |
| Common Stock | $4.5K | $4.5K | $4.4K | $4.3K | $4.1K | $823 | $21K | $419 |
| Retained Earnings | -$234.0M | -$231.4M | -$228.8M | -$226.6M | -$224.3M | -$221.3M | -$219.0M | -$216.8M |
| **Total Stockholders' Equity** | $1.09M | $3.67M | $6.18M | $8.28M | $9.83M | -$2.13M | $138K | -$212K |
| Total Equity | $1.09M | $3.67M | $6.18M | $8.28M | $9.83M | -$2.13M | $138K | -$212K |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$9.84M | -$10.57M | -$20.66M | -$14.29M | -$15.71M | -$26.43M | -$15.57M | -$9.91M | -$6.73M | -$7.01M |
| Depreciation & Amortization | -- | -- | $27K | $45K | $41K | $52K | $63K | $30K | $66K | $75K |
| Stock-Based Compensation | $642K | $516K | $1.02M | $742K | $1.69M | $1.49M | $553K | $996K | -- | -- |
| **Operating Cash Flow** | -$9.25M | -$8.60M | -$7.29M | -$15.23M | -$13.47M | -$16.95M | -$13.01M | -$9.08M | -$6.36M | -$7.08M |
| Capital Expenditure | -- | -- | -- | -$128K | -$44K | -- | -$25K | -$125K | -- | -$27K |
| **Free Cash Flow** | -- | -- | -- | -$15.36M | -$13.51M | -- | -$13.04M | -$9.20M | -- | -$7.10M |
| **Investing Cash Flow** | -- | -- | -$936K | -$116K | -$44K | -- | -$25K | -$125K | -- | $1.68M |
| Common Stock Issued | $2.63M | $6.67M | $800K | $69K | $26.68M | $11.34M | -- | $13.80M | $9.68M | $2.64M |
| **Financing Cash Flow** | $16.78M | $5.98M | $284K | -$495K | $23.14M | $16.32M | $11.10M | $23.25M | $8.45M | $4.45M |
| **Net Change in Cash** | $7.53M | -$2.62M | -$7.94M | -$15.84M | $9.63M | -$628K | -$1.94M | $14.04M | $2.09M | -$949K |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$2.60M | -$2.53M | -$2.20M | -$2.29M | -$3.07M | -$2.27M | -$2.22M | -$3.35M |
| Stock-Based Compensation | $25K | $18K | $17K | $612K | $6.0K | $6.8K | $18K | $58K |
| **Operating Cash Flow** | -$2.03M | -$2.19M | -$2.20M | -$2.84M | -$2.98M | -$1.31M | -$2.11M | -$2.02M |
| **Investing Cash Flow** | $0 | $0 | $4.00M | -- | -- | -- | -- | -- |
| Common Stock Issued | $0 | $0 | $79K | -$1.1K | $0 | $0 | $2.64M | $2.0K |
| **Financing Cash Flow** | $397K | -$56K | -$92K | -$169K | $12.41M | -$133K | $4.67M | -$261K |
| **Net Change in Cash** | -$1.64M | -$2.24M | $1.71M | -$3.00M | $9.43M | -$1.45M | $2.56M | -$2.28M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | -- | -- | -55519.9% | -10964.6% | -18130.3% | -- | -- | -- | -- | -- |
| **Net Profit Margin** | -- | -- | -54858.1% | -10864.0% | -18062.0% | -- | -- | -- | -- | -- |
| Return on Equity (ROE) | -118.9% | -- | -652.0% | -109.8% | -59.3% | -156.9% | -90.3% | -47.5% | -106.6% | -236.5% |
| Return on Assets (ROA) | -97.8% | -717.7% | -415.9% | -96.8% | -55.7% | -141.5% | -78.8% | -45.0% | -93.3% | -162.8% |
| Current Ratio | -- | -- | 2.15x | 8.95x | 19.17x | 13.40x | 10.18x | 18.79x | 8.01x | 3.14x |
| Quick Ratio | -- | -- | 1.94x | 7.16x | 18.87x | 13.14x | 9.87x | 17.31x | 6.86x | 3.14x |
| Debt to Equity | -- | -- | 0.00x | 0.03x | 0.02x | 0.04x | 0.05x | -- | -- | -- |
| **Revenue Growth (YoY)** | -- | -- | -71.4% | +51.2% | -- | -- | -- | -- | -- | -- |
| 5Y Revenue / Share Growth | -- | -- | -- | -- | -- | -- | -- | -- | -100.0% | -100.0% |
| 10Y Revenue / Share Growth | -- | -- | -99.9% | -99.9% | -98.1% | -- | -- | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -880.6% | -274.7% | -159.0% | -118.9% | -110.9% | -- | -7505.4% | -- |
| Return on Assets (ROA) | -293.1% | -183.6% | -131.2% | -97.8% | -85.8% | -481.4% | -267.1% | -717.7% |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
